4 引文 斯高帕斯(Scopus)

摘要

Although cell-based therapy has become a promising treatment, its practice and evaluation process remain unstandardized. Therefore, Japan initiated a dual-track regulatory framework for cell-based therapy aiming to promote and regulate the therapies to ensure that patients can access safe and effective treatments. Influenced by such pathway, Taiwan adopted the framework and initiated its own cell-based therapy regulation in 2018. This paper discusses how Japan has influenced Taiwan in developing regulations for cell-based therapy.

原文英語
頁(從 - 到)1045-1047
頁數3
期刊Clinical and Translational Science
13
發行號6
DOIs
出版狀態已發佈 - 11月 2020

ASJC Scopus subject areas

  • 一般神經科學
  • 一般生物化學,遺傳學和分子生物學
  • 藥理學、毒理學和藥劑學 (全部)

指紋

深入研究「Adoption of Regulations for Cell Therapy Development: Linkage Between Taiwan and Japan」主題。共同形成了獨特的指紋。

引用此